SciClone Pharmaceuticals

At SciClone (Stock code: 6600.TW) , our vision is by focusing on treatments of severe and specialized disease areas, we are dedicated to becoming a top-tier China-focused specialty pharmaceutical company with sustainable growth by working hard to win trust from our patients, respect from our customers and pride from our employees. With more than 20+ years’ experience of commercializing differentiated high quality medicines in the China market, our vision serves as the framework for our roadmap and guides every aspect of our business. We intend to leverage our product development and commercialization capabilities to capitalize on the large growth potential of the market for oncology and severe infection.